Perfectenergy International Signs 50 MW Solar Sales Contract With Abidas AG

Perfectenergy International Limited (OTCBB:PFGY), a global manufacturer and marketer of customized and standard photovoltaic ("PV") solar cells, modules and systems, today announced that its subsidiary, Perfectenergy (Shanghai) Co. Ltd., has entered into a sales contract valued at more than $150 million with Abidas AG of Germany, pursuant to which Abidas will purchase 50 MW of mono solar modules from Perfectenergy scheduled for delivery over the next four quarters of 2009. Perfectenergy's total PV module order-backlog since October 2008 exceeds $170 million for calendar year of 2009.

Jack Li, chief executive officer of Perfectenergy commented: "We are very pleased to announce our business relationship with Abidas, who is a well-known energy consultant and systems integrator based in Germany with significant projects throughout Europe. This contract demonstrates the growth potential of our photovoltaic module product line."

The photovoltaic modules will be manufactured at Perfectenergy's 60-megawatt factory in Shanghai, China. Prices reflect market conditions and are fixed until June 2009 when they will be fixed again based on market developments. Perfectenergy currently has fixed sufficient silicon supplies for meeting its production demands for 2009.

The multibillion-dollar photovoltaic industry has thrived in recent years as the solar market has expanded in Japan, Germany, Spain, and the United States. According to the European Photovoltaic Industry Association (EPIA), by 2030 cumulative global installed capacity will reach 728 gigawatts, which will achieve electricity production of 1,027 terawatt hours.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.